Track the Roquefort Therapeutics plc share price and the full directors' dealings record of the company, a listed issuer based in United Kingdom. Shares are quoted on the UK market, under the oversight of RNS (LSE). The latest transaction was reported on 24 November 2025 (Purchase). Among the most active insiders: Stephen West. All data is openly available.
10
Insider Decl.
n/a
Thresholds
€189,302
9 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
Buys €189,302n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
028,715 purchased off-market 6,550 purchased on London Stock Exchange (XLON); Main MarketISINISIN GB00BMDQ2T15RNS:4814176
10 of 10 declarations
About Roquefort Therapeutics plc
Roquefort Therapeutics plc is a company listed on the XLON market, focused on developing innovative therapeutic treatments. It aims to provide solutions for serious and unmet medical needs.